Caifeng Fu

PAREXEL International (United States) — United States

Medicine · Health Sciences

9h-index5.0kcitations15works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(6), Advanced Glycation End Products research(5), HIV Research and Treatment(3), Gastroesophageal reflux and treatments(3), Helicobacter pylori-related gastroenterology studies(2)

Publications15 total

Newborn screening for primary carnitine deficiency in Quanzhou, China
Clinica Chimica Acta·2020· 20 cited
<p>The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet</p>
Clinical Pharmacology Advances and Applications·2020· 3 citedOpen Access
Bioequivalence and Food Effect Assessment of 2 Fixed‐Dose Combination Formulations of Dolutegravir and Lamivudine
Clinical Pharmacology in Drug Development·2019· 9 citedOpen Access
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Adults With Severe Renal Impairment and Healthy Matched Control Participants
Clinical Pharmacology in Drug Development·2019· 23 citedOpen Access
Bioequivalence of a Fixed-Dose Combination Tablet of the Complete Two-Drug Regimen of Dolutegravir and Rilpivirine for Treatment of HIV-1 Infection
Antimicrobial Agents and Chemotherapy·2018· 8 citedOpen Access
Pharmacokinetics of Cabotegravir in Subjects with Severe Renal Impairment
Open Forum Infectious Diseases·2017· 5 citedOpen Access
Cabotegravir(CAB) Safety Meta-analysis Update from 14 Phase I/IIa Studies
Open Forum Infectious Diseases·2016Open Access
Pharmacodynamics and Safety of Pantoprazole in Neonates, Preterm Infants, and Infants Aged 1 Through 11 Months with a Clinical Diagnosis of Gastroesophageal Reflux Disease
Digestive Diseases and Sciences·2010· 25 cited
M1908 Pharmacodynamics (PD) and Safety of Pantoprazole Delayed-Release Granules in Infants Aged 1 Through 11 Months with a Clinical Diagnosis of Gastroesophageal Reflux Disease (GERD)
Gastroenterology·2009· 2 cited
Pharmacokinetics of Two Dose Levels of Pantoprazole Sodium Delayed-Release Granules for Oral Suspension in Infants Aged 1 Through 11 Months with a Presumed Diagnosis of GERD
The American Journal of Gastroenterology·2008· 3 cited
Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE
Circulation·2002· 535 cited
Expression of Advanced Glycation End Products and Their Cellular Receptor RAGE in Diabetic Nephropathy and Nondiabetic Renal Disease
Journal of the American Society of Nephrology·2000· 476 cited
Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases
Nature·2000· 1.2k cited
N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression
Journal of Biological Chemistry·1999· 860 citedOpen Access
RAGE Mediates a Novel Proinflammatory Axis
Cell·1999· 1.8k citedOpen Access

Frequent Co-authors

Ann Marie Schmidt(5), Thomas Kislinger(4), David M. Stern(4), Allan R. Tenorio(4), M. Hofmann(3), Wu Qu(3), Jarosław Kierkuś(3), Natalie Rath(3), Mary K. Maguire(3), Gail M. Comer(3), Kalpana Bakshi(3), William Spreen(3), Parul Patel(3), Allen Wolstenholme(3), Kimberly K. Adkison(3), Akihiko Taguchi(2), Akihiko Taguchi(2), Nozomu Tanji(2), Monika Pischetsrieder(2), Wanda Furmaga-Jabłońska(2)